SPG11 Protein

SPG11 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">SPG11 (Spatacsin)</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>SPG11</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q96MC7" target="_blank">Q96MC7</a></td>
</tr>
<tr>
<td class="label">PDB</td>
<td>No structures deposited</td>
</tr>
<tr>
<td class="label">Mol. Weight</td>
<td>~2,800 amino acids (~280 kDa)</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Cytoplasm, Endosomes, Lysosomes</td>
</tr>
<tr>
<td class="label">Family</td>
<td>Spatacsin family</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Hereditary Spastic Paraplegia](/diseases/spastic-paraplegia), [ALS](/diseases/als)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/neurodegeneration" style="color:#ef9a9a">Neurodegeneration</a>, <a href="/wiki/neuroinflammation" style="color:#ef9a9a">Neuroinflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">13 edges</a></td>
</tr>
</table>

SPG11 (Spatacsin)

Overview

SPG11 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">SPG11 (Spatacsin)</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>SPG11</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q96MC7" target="_blank">Q96MC7</a></td>
</tr>
<tr>
<td class="label">PDB</td>
<td>No structures deposited</td>
</tr>
<tr>
<td class="label">Mol. Weight</td>
<td>~2,800 amino acids (~280 kDa)</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Cytoplasm, Endosomes, Lysosomes</td>
</tr>
<tr>
<td class="label">Family</td>
<td>Spatacsin family</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Hereditary Spastic Paraplegia](/diseases/spastic-paraplegia), [ALS](/diseases/als)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/neurodegeneration" style="color:#ef9a9a">Neurodegeneration</a>, <a href="/wiki/neuroinflammation" style="color:#ef9a9a">Neuroinflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">13 edges</a></td>
</tr>
</table>

SPG11 (Spatacsin)

Overview

SPG11, also known as Spatacsin, is a massive protein of approximately 2,800 amino acids encoded by the SPG11 gene. It belongs to the spatacsin family of proteins involved in cellular trafficking and [autophagy](/entities/autophagy)[@berciano2022]. SPG11 is one of the most common genes causing autosomal recessive hereditary spastic paraplegia (HSP) and is also associated with juvenile-onset ALS and intellectual disability[@marti2021]. The protein plays critical roles in endolysosomal trafficking, autophagy, and the formation of tubular lysosomes, all of which are essential for neuronal survival[@varga2023].

Structure

SPG11 is a very large protein (~280 kDa) with a complex domain architecture that remains incompletely characterized. The protein contains multiple alpha-helical domains and is predicted to be a peripheral membrane protein that associates with the cytoplasmic face of endosomes and lysosomes[@zhang2022]. The lack of available PDB structures reflects the challenges in expressing and crystallizing such large proteins. The protein's predicted structure can be explored via the [AlphaFold Protein Structure Database](https://alphafold.ebi.ac.uk/entry/Q96MC7).

Normal Function

Under physiological conditions, SPG11 performs essential functions in neuronal cells. The protein is a key regulator of endolysosomal system morphology and function, particularly in the maintenance of tubular lysosomes and autophagosome-lysosome fusion[@boutry2022]. SPG11 forms a complex with another HSP protein, SPG15 (ZFYVE26), to regulate the initiation of autophagy and the maturation of autophagosomes[@hirst2021].

In [neurons](/entities/neurons), SPG11 participates in several critical processes:

• Endolysosomal trafficking: SPG11 regulates the movement and function of endosomes and lysosomes along microtubules, essential for neuronal homeostasis[@renvoise2022]
• Autophagy: SPG11 is required for proper autophagosome formation and fusion with lysosomes, critical for clearing misfolded proteins and damaged organelles[@chang2023]
• Lysosomal tubular network: SPG11 maintains the tubular lysosomal network important for cellular waste removal and nutrient recycling[@liu2021]
• Corticospinal tract development: SPG11 is essential for the development and maintenance of upper motor neurons whose axons comprise the corticospinal tract[@klebe2020]

Role in Disease

Hereditary Spastic Paraplegia (HSP)

Mutations in SPG11 are the most common cause of autosomal recessive complex HSP, accounting for approximately 20-25% of cases[@marti2022]. The clinical phenotype typically includes early-onset progressive spasticity and weakness of the lower limbs (pure HSP) accompanied by additional neurological features (complex HSP) such as intellectual disability, thin corpus callosum, seizures, and parkinsonism[@faber2021]. SPG11-related HSP typically presents in childhood or adolescence and progresses to severe disability over decades. Neuropathological studies reveal loss of upper motor neurons in the motor [cortex](/brain-regions/cortex) and degeneration of corticospinal tract axons[@schneider2023].

Amyotrophic Lateral Sclerosis (ALS)

Biallelic loss-of-function mutations in SPG11 cause a form of juvenile-onset ALS with frontotemporal dementia[@benatar2022]. This overlap between HSP and ALS underscores the shared mechanisms of upper motor neuron degeneration. Cellular models demonstrate that SPG11 deficiency leads to impaired autophagic flux, accumulation of damaged mitochondria, and increased susceptibility to oxidative stress—hallmarks of ALS pathogenesis[@goncalves2023].

Intellectual Disability

SPG11 mutations are also associated with nonsyndromic intellectual disability without spastic paraplegia, indicating that the protein has essential functions in cognitive development beyond motor neuron maintenance[@leno2021].

Therapeutic Targeting

SPG11 represents a challenging but important therapeutic target for HSP and ALS[@oleary2023]:

• Gene therapy: AAV-mediated delivery of wild-type SPG11 to replace defective copies in neurons
• Autophagy modulators: Small molecules that enhance autophagic flux to compensate for SPG11 deficiency
• Lysosomal function enhancers: Drugs that improve lysosomal trafficking and function
• Neuroprotective agents: Antioxidants and mitochondrial protectants to reduce oxidative damage

Key Publications

External Links

• UniProt: [https://www.uniprot.org/uniprot/Q96MC7](https://www.uniprot.org/uniprot/Q96MC7)
• AlphaFold: [SPG11](https://alphafold.ebi.ac.uk/entry/Q96MC7)
• GeneCards: [SPG11](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SPG11)
• OMIM: [SPG11](https://www.omim.org/entry/607504)

See Also

• [Proteins Index](/proteins)
• [Genes Index](/genes)
• [Diseases Index](/diseases)
• [Mechanisms Index](/mechanisms)
• [Hereditary Spastic Paraplegia](/diseases/spastic-paraplegia)
• [ALS](/diseases/als)
• [SPG15](/proteins/spg15-protein)
• [CHCHD10](/proteins/chchd10-protein)
• [VCP](/proteins/vcp-protein)

References